for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Healius Ltd

hls.ax

Latest Trade

3.32AUD

Change

-0.01(-0.30%)

Volume

3,468,303

Today's Range

3.28

 - 

3.35

52 Week Range

1.92

 - 

3.46

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
3.33
Open
3.33
Volume
3,468,303
3M AVG Volume
49.77
Today's High
3.35
Today's Low
3.28
52 Week High
3.46
52 Week Low
1.92
Shares Out (MIL)
622.74
Market Cap (MIL)
2,074.62
Forward P/E
23.01
Dividend (Yield %)
0.78

Latest Developments

More

Healius Posts FY Underlying Profit After Tax Of $55.4 Mln Vs $70.3 Mln

Healius Expects FY Underlying EBIT Of About $102-104 Million

Healius Announces Sale Of Medical Centres For $500 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Healius Ltd

Healius Ltd, formerly Primary Health Care Limited is a medical center operator. The Company also operates as a provider of diagnostic imaging services; a provider of pathology services, and a provider of health technology. It provides a range of services and facilities to healthcare practitioners, and its medical center operations include the provision of day surgery and in vitro fertilization services by healthcare practitioners. Its segments include Medical Centres, Pathology, Imaging, Health Technology and Other. The Medical Centres division provides services and facilities to general practitioners, specialists and other healthcare providers, and includes Transport Health. The Pathology division provides pathology services. The Imaging division provides imaging and scanning services from standalone imaging sites and from within the consolidated entity's medical centers. The Health Technology division develops, sells and supports health-related software products.

Industry

Healthcare Facilities

Contact Info

L 6 203 Pacific Hwy, St Leonards

SYDNEY, NSW

2065

Australia

+61.2.94329400

https://www.healius.com.au/

Executive Leadership

Robert Hubbard

Independent Non-Executive Chairman of the Board

Malcolm W. Parmenter

Chief Executive Officer, Managing Director, Director

Maxine Jaquet

Chief Financial Officer

Timothy Haggett

Chief Executive - Medical Centres

Wesley Lawrence

Chief Executive - Pathology

Key Stats

2.50 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, AUD)

2018

1.7K

2019

1.8K

2020

1.6K

2021(E)

1.8K
EPS (AUD)

2018

0.171

2019

0.153

2020

0.089

2021(E)

0.145
Price To Earnings (TTM)
28.82
Price To Sales (TTM)
1.31
Price To Book (MRQ)
1.07
Price To Cash Flow (TTM)
7.15
Total Debt To Equity (MRQ)
90.50
LT Debt To Equity (MRQ)
81.50
Return on Investment (TTM)
2.20
Return on Equity (TTM)
1.82

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up